Xperi Inc
NYSE:XPER
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Xperi Inc
NYSE:XPER
|
US |
|
Renaissance Global Ltd
BSE:532923
|
IN |
|
B
|
Bendigo and Adelaide Bank Ltd
OTC:BXRBF
|
AU |
|
G
|
Greenidge Generation Holdings Inc
NASDAQ:GREE
|
US |
|
Aeterna Zentaris Inc
TSX:AEZS
|
US |
|
N
|
NextCell Pharma AB
STO:NXTCL
|
SE |
|
Lion Copper and Gold Corp
XTSX:LEO
|
CA |
|
Subsea 7 SA
OSE:SUBC
|
UK |
|
Afry AB
STO:AFRY
|
SE |
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
IN |
|
Katoro Gold PLC
LSE:KAT
|
UK |
|
Drone Delivery Canada Corp
XTSX:FLT
|
CA |
|
Spotify Technology SA
NYSE:SPOT
|
LU |
Wall St Price Targets
XPER Price Targets Summary
Xperi Inc
According to Wall Street analysts, the average 1-year price target for
XPER is 11.63 USD with a low forecast of 9.09 USD and a high forecast of 13.65 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XPER's stock price target?
Price Target
11.63
USD
According to Wall Street analysts, the average 1-year price target for
XPER is 11.63 USD with a low forecast of 9.09 USD and a high forecast of 13.65 USD.
What is the Revenue forecast for Xperi Inc?
Projected CAGR
9%
Over the last 5 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 9%.